144 related articles for article (PubMed ID: 37575059)
1. Ketone ester administration improves glycemia in obese mice.
Tabatabaei Dakhili SA; Yang K; Locatelli CAA; Saed CT; Greenwell AA; Chan JSF; Chahade JJ; Scharff J; Al-Imarah S; Eaton F; Crawford PA; Gopal K; Mulvihill EE; Ussher JR
Am J Physiol Cell Physiol; 2023 Sep; 325(3):C750-C757. PubMed ID: 37575059
[TBL] [Abstract][Full Text] [Related]
2. Defective muscle ketone body oxidation disrupts BCAA catabolism by altering mitochondrial branched-chain aminotransferase.
Mechchate H; Abdualkader AM; Bernacchi JB; Gopal K; Tabatabaei Dakhili SA; Yang K; Greenwell AA; Kong X; Crawford PA; Al Batran R
Am J Physiol Endocrinol Metab; 2023 May; 324(5):E425-E436. PubMed ID: 36989424
[TBL] [Abstract][Full Text] [Related]
3. Pimozide Alleviates Hyperglycemia in Diet-Induced Obesity by Inhibiting Skeletal Muscle Ketone Oxidation.
Al Batran R; Gopal K; Capozzi ME; Chahade JJ; Saleme B; Tabatabaei-Dakhili SA; Greenwell AA; Niu J; Almutairi M; Byrne NJ; Masson G; Kim R; Eaton F; Mulvihill EE; Garneau L; Masters AR; Desta Z; Velázquez-Martínez CA; Aguer C; Crawford PA; Sutendra G; Campbell JE; Dyck JRB; Ussher JR
Cell Metab; 2020 May; 31(5):909-919.e8. PubMed ID: 32275862
[TBL] [Abstract][Full Text] [Related]
4. Ketones can become the major fuel source for the heart but do not increase cardiac efficiency.
Ho KL; Karwi QG; Wagg C; Zhang L; Vo K; Altamimi T; Uddin GM; Ussher JR; Lopaschuk GD
Cardiovasc Res; 2021 Mar; 117(4):1178-1187. PubMed ID: 32402081
[TBL] [Abstract][Full Text] [Related]
5. Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency.
Ho KL; Zhang L; Wagg C; Al Batran R; Gopal K; Levasseur J; Leone T; Dyck JRB; Ussher JR; Muoio DM; Kelly DP; Lopaschuk GD
Cardiovasc Res; 2019 Sep; 115(11):1606-1616. PubMed ID: 30778524
[TBL] [Abstract][Full Text] [Related]
6. β-Hydroxybutyrate is reduced in humans with obesity-related NAFLD and displays a dose-dependent effect on skeletal muscle mitochondrial respiration in vitro.
Mey JT; Erickson ML; Axelrod CL; King WT; Flask CA; McCullough AJ; Kirwan JP
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E187-E195. PubMed ID: 32396388
[TBL] [Abstract][Full Text] [Related]
7. Ketones provide an extra source of fuel for the failing heart without impairing glucose oxidation.
Pherwani S; Connolly D; Sun Q; Karwi QG; Carr M; Ho KL; Wagg CS; Zhang L; Levasseur J; Silver H; Dyck JRB; Lopaschuk GD
Metabolism; 2024 May; 154():155818. PubMed ID: 38369056
[TBL] [Abstract][Full Text] [Related]
8. Diminished ketone interconversion, hepatic TCA cycle flux, and glucose production in D-β-hydroxybutyrate dehydrogenase hepatocyte-deficient mice.
Stagg DB; Gillingham JR; Nelson AB; Lengfeld JE; d'Avignon DA; Puchalska P; Crawford PA
Mol Metab; 2021 Nov; 53():101269. PubMed ID: 34116232
[TBL] [Abstract][Full Text] [Related]
9. Chronically Elevating Circulating Ketones Can Reduce Cardiac Inflammation and Blunt the Development of Heart Failure.
Byrne NJ; Soni S; Takahara S; Ferdaoussi M; Al Batran R; Darwesh AM; Levasseur JL; Beker D; Vos DY; Schmidt MA; Alam AS; Maayah ZH; Schertzer JD; Seubert JM; Ussher JR; Dyck JRB
Circ Heart Fail; 2020 Jun; 13(6):e006573. PubMed ID: 32493060
[TBL] [Abstract][Full Text] [Related]
10. The therapeutic potential of ketones in cardiometabolic disease: impact on heart and skeletal muscle.
Soni S; Tabatabaei Dakhili SA; Ussher JR; Dyck JRB
Am J Physiol Cell Physiol; 2024 Feb; 326(2):C551-C566. PubMed ID: 38193855
[TBL] [Abstract][Full Text] [Related]
11. The Antipsychotic Dopamine 2 Receptor Antagonist Diphenylbutylpiperidines Improve Glycemia in Experimental Obesity by Inhibiting Succinyl-CoA:3-Ketoacid CoA Transferase.
Tabatabaei Dakhili SA; Greenwell AA; Yang K; Abou Farraj R; Saed CT; Gopal K; Chan JSF; Chahade JJ; Eaton F; Lee C; Velázquez-Martínez CA; Crawford PA; Glover JNM; Al Batran R; Ussher JR
Diabetes; 2023 Jan; 72(1):126-134. PubMed ID: 36256885
[TBL] [Abstract][Full Text] [Related]
12. Impact of peripheral ketolytic deficiency on hepatic ketogenesis and gluconeogenesis during the transition to birth.
Cotter DG; Ercal B; d'Avignon DA; Dietzen DJ; Crawford PA
J Biol Chem; 2013 Jul; 288(27):19739-49. PubMed ID: 23689508
[TBL] [Abstract][Full Text] [Related]
13. A ketone monoester drink reduces the glycemic response to an oral glucose challenge in individuals with obesity: a randomized trial.
Myette-Côté É; Caldwell HG; Ainslie PN; Clarke K; Little JP
Am J Clin Nutr; 2019 Dec; 110(6):1491-1501. PubMed ID: 31599919
[TBL] [Abstract][Full Text] [Related]
14. β-Hydroxybutyrate elevation as a compensatory response against oxidative stress in cardiomyocytes.
Nagao M; Toh R; Irino Y; Mori T; Nakajima H; Hara T; Honjo T; Satomi-Kobayashi S; Shinke T; Tanaka H; Ishida T; Hirata K
Biochem Biophys Res Commun; 2016 Jul; 475(4):322-8. PubMed ID: 27216458
[TBL] [Abstract][Full Text] [Related]
15. Prolonged β
van Beek SMM; Kalinovich A; Schaart G; Bengtsson T; Hoeks J
Am J Physiol Endocrinol Metab; 2021 Mar; 320(3):E619-E628. PubMed ID: 33522400
[TBL] [Abstract][Full Text] [Related]
16. Exogenous Ketones Lower Blood Glucose Level in Rested and Exercised Rodent Models.
Ari C; Murdun C; Koutnik AP; Goldhagen CR; Rogers C; Park C; Bharwani S; Diamond DM; Kindy MS; D'Agostino DP; Kovács Z
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31581549
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects on kidney during treatment with sodium-glucose cotransporter 2 inhibitors: proposed role of ketone utilization.
Hattori Y
Heart Fail Rev; 2021 Jul; 26(4):947-952. PubMed ID: 33404998
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Acute Ingestion of a Ketone Monoester Drink on LPS-Stimulated NLRP3 Activation in Humans with Obesity.
Neudorf H; Myette-Côté É; P Little J
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32209983
[TBL] [Abstract][Full Text] [Related]
19. Tbc1d1 deletion suppresses obesity in leptin-deficient mice.
Dokas J; Chadt A; Joost HG; Al-Hasani H
Int J Obes (Lond); 2016 Aug; 40(8):1242-9. PubMed ID: 27089993
[TBL] [Abstract][Full Text] [Related]
20. Ketone Ester D-β-Hydroxybutyrate-(R)-1,3 Butanediol Prevents Decline in Cardiac Function in Type 2 Diabetic Mice.
Thai PN; Miller CV; King MT; Schaefer S; Veech RL; Chiamvimonvat N; Bers DM; Dedkova EN
J Am Heart Assoc; 2021 Oct; 10(19):e020729. PubMed ID: 34583524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
